Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Comorbid Allergic Rhinitis

Main Article Content

Jonathan Spergel
Michael Blaiss
Peter Lio
Aharon Kessel
Liza Takiya
John Werth
Michael O'Connell
Chuanbo Zang
Michael Cork

Keywords

Atopic Dermatitis, Allergic Rhinitis, Crisaborole, Efficacy, Safety

Abstract

Abstract not available.

References

1. Dharmage SC et al. Allergy. 2014;69:17-27.

2. Silverberg JI. Ann Allergy Asthma Immunol. 2019;123:144-151.

3. Silverberg JI. Clin Dermatol. 2017;35:360-366.

4. Eucrisa (crisaborole) ointment, 2%, for topical use [package insert]. New York, NY: Pfizer Labs; April 2020.

5. Paller AS et al. J Am Acad Dermatol. 2016;75:494-503.e496.

6. Hanifin JM, Rajka G. Acta Derm Venereol. 1980;60:44-47.

7. Yosipovitch G et al. Itch. 2018;3:e13.